EA201201571A1 - Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей - Google Patents
Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солейInfo
- Publication number
- EA201201571A1 EA201201571A1 EA201201571A EA201201571A EA201201571A1 EA 201201571 A1 EA201201571 A1 EA 201201571A1 EA 201201571 A EA201201571 A EA 201201571A EA 201201571 A EA201201571 A EA 201201571A EA 201201571 A1 EA201201571 A1 EA 201201571A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- synthesis
- pharmaceutically acceptable
- acceptable acid
- ivabradin
- new method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Способ синтеза ивабрадина формулы (I)его фармацевтически приемлемых кислотно-аддитивных солей и его гидратов. Лекарственные средства.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1103934A FR2984320B1 (fr) | 2011-12-20 | 2011-12-20 | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201201571A1 true EA201201571A1 (ru) | 2013-07-30 |
EA021713B1 EA021713B1 (ru) | 2015-08-31 |
Family
ID=47355960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201201571A EA021713B1 (ru) | 2011-12-20 | 2012-12-19 | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей |
Country Status (35)
Country | Link |
---|---|
US (1) | US8507668B2 (ru) |
EP (1) | EP2607354B1 (ru) |
JP (1) | JP5531084B2 (ru) |
KR (1) | KR101479986B1 (ru) |
CN (1) | CN103172567B (ru) |
AR (1) | AR089325A1 (ru) |
AU (1) | AU2012261583B2 (ru) |
BR (1) | BR102012032562A2 (ru) |
CA (1) | CA2798633C (ru) |
CL (1) | CL2012003579A1 (ru) |
CY (1) | CY1115620T1 (ru) |
DK (1) | DK2607354T3 (ru) |
EA (1) | EA021713B1 (ru) |
ES (1) | ES2516290T3 (ru) |
FR (1) | FR2984320B1 (ru) |
GE (1) | GEP20156245B (ru) |
HK (1) | HK1186734A1 (ru) |
HR (1) | HRP20140839T1 (ru) |
JO (1) | JO3083B1 (ru) |
MA (1) | MA34868B1 (ru) |
MD (1) | MD4275C1 (ru) |
MX (1) | MX2012014321A (ru) |
MY (1) | MY160928A (ru) |
PE (1) | PE20131325A1 (ru) |
PL (1) | PL2607354T3 (ru) |
PT (1) | PT2607354E (ru) |
RS (1) | RS53470B (ru) |
SA (1) | SA112340106B1 (ru) |
SG (1) | SG191498A1 (ru) |
SI (1) | SI2607354T1 (ru) |
TW (1) | TWI440628B (ru) |
UA (1) | UA111156C2 (ru) |
UY (1) | UY34508A (ru) |
WO (1) | WO2013093333A1 (ru) |
ZA (1) | ZA201209369B (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2988720B1 (fr) * | 2012-03-27 | 2014-03-14 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2868776B1 (fr) * | 2004-04-13 | 2008-04-18 | Servier Lab | Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2868775B1 (fr) * | 2004-04-13 | 2008-04-11 | Servier Lab | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2870537A1 (fr) * | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
KR101478855B1 (ko) * | 2007-05-30 | 2015-01-02 | 인드-스위프트 래버러토리즈 리미티드 | 이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법 |
FR2920773B1 (fr) * | 2007-09-11 | 2009-10-23 | Servier Lab | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2935381B1 (fr) * | 2008-08-29 | 2010-12-17 | Servier Lab | Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine |
FR2940287B1 (fr) * | 2008-12-24 | 2010-12-24 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
FR2941695B1 (fr) * | 2009-02-04 | 2011-02-18 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
CA2752744A1 (en) * | 2009-02-17 | 2010-08-26 | Mallinckrodt Inc. | Process for the reductive alkylation of normorphinans |
ME00986B (me) * | 2009-03-31 | 2012-06-20 | Servier Lab | Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom |
-
2011
- 2011-12-20 FR FR1103934A patent/FR2984320B1/fr not_active Expired - Fee Related
-
2012
- 2012-12-04 SG SG2012089041A patent/SG191498A1/en unknown
- 2012-12-05 PE PE2012002275A patent/PE20131325A1/es active IP Right Grant
- 2012-12-06 JO JOP/2012/0370A patent/JO3083B1/ar active
- 2012-12-07 MY MYPI2012701116A patent/MY160928A/en unknown
- 2012-12-07 AU AU2012261583A patent/AU2012261583B2/en not_active Ceased
- 2012-12-07 MX MX2012014321A patent/MX2012014321A/es active IP Right Grant
- 2012-12-11 CA CA2798633A patent/CA2798633C/fr not_active Expired - Fee Related
- 2012-12-11 ZA ZA2012/09369A patent/ZA201209369B/en unknown
- 2012-12-11 UY UY0001034508A patent/UY34508A/es unknown
- 2012-12-14 US US13/714,950 patent/US8507668B2/en not_active Expired - Fee Related
- 2012-12-14 MD MDA20120123A patent/MD4275C1/ru not_active IP Right Cessation
- 2012-12-18 KR KR20120148761A patent/KR101479986B1/ko active IP Right Grant
- 2012-12-18 UA UAA201214527A patent/UA111156C2/uk unknown
- 2012-12-18 GE GEAP201212929A patent/GEP20156245B/en unknown
- 2012-12-18 SA SA112340106A patent/SA112340106B1/ar unknown
- 2012-12-19 BR BR102012032562-4A patent/BR102012032562A2/pt not_active Application Discontinuation
- 2012-12-19 RS RS20140425A patent/RS53470B/en unknown
- 2012-12-19 MA MA35475A patent/MA34868B1/fr unknown
- 2012-12-19 WO PCT/FR2012/052982 patent/WO2013093333A1/fr active Application Filing
- 2012-12-19 DK DK12197929.8T patent/DK2607354T3/da active
- 2012-12-19 PL PL12197929T patent/PL2607354T3/pl unknown
- 2012-12-19 CL CL2012003579A patent/CL2012003579A1/es unknown
- 2012-12-19 CN CN201210554758.0A patent/CN103172567B/zh not_active Expired - Fee Related
- 2012-12-19 PT PT121979298T patent/PT2607354E/pt unknown
- 2012-12-19 SI SI201230075T patent/SI2607354T1/sl unknown
- 2012-12-19 EA EA201201571A patent/EA021713B1/ru not_active IP Right Cessation
- 2012-12-19 EP EP12197929.8A patent/EP2607354B1/fr active Active
- 2012-12-19 ES ES12197929.8T patent/ES2516290T3/es active Active
- 2012-12-19 JP JP2012276524A patent/JP5531084B2/ja active Active
- 2012-12-19 AR ARP120104818A patent/AR089325A1/es unknown
- 2012-12-19 TW TW101148518A patent/TWI440628B/zh not_active IP Right Cessation
-
2013
- 2013-12-23 HK HK13114206.6A patent/HK1186734A1/xx not_active IP Right Cessation
-
2014
- 2014-09-04 HR HRP20140839AT patent/HRP20140839T1/hr unknown
- 2014-10-14 CY CY20141100833T patent/CY1115620T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201101147A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201000398A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201200498A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201200123A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201100230A1 (ru) | Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
EA201000397A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201201385A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201400473A1 (ru) | Способ синтеза 3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбонитрила и применение для синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
UA118008C2 (uk) | Спосіб синтезу (2е)-3-(3,4-диметоксифеніл)проп-2-еннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою | |
EA201301235A1 (ru) | Новый способ синтеза 3-(2-бром-4,5-диметоксифенил)пропаннитрила и применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201201571A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201300281A2 (ru) | Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
UA117655C2 (uk) | Спосіб синтезу 3-(2-бромо-4,5-диметоксифеніл)пропаннітрілу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою | |
EA201400269A1 (ru) | Способ синтеза соединений 7,8-диметокси -1,3-дигидро-2h-3-бензазепин-2-она и применение в синтезе ивабрадина | |
IN2013MN01164A (ru) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |